InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Morrison Jodie Pope. Officer active across 2 companies, notably Tokai Pharmaceuticals Inc. In total, 9 disclosures have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €261k. Activity tracked since 24 February 2025. The latest transaction was filed on 25 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Morrison Jodie Pope is a declarant linked to Q32 Bio Inc. and Tokai Pharmaceuticals Inc, where the listed role is CEO for the former and President and CEO for the latter. Across 8 filings in total, the 8 sampled filings run from 2016-01-08 to 2026-07-20 and show EUR 0 in buys and EUR 121263 in sells, with transaction nature listed as Attribution.